Today's message from Zeiss:
"With just a few weeks to go, we are sure you are planning your schedule for the upcoming EANS2018, in Brussels, Belgium. We want to give you some heads-up about our activities so you can reserve your time to visit the ZEISS Booth #5 (on level -2).
Visit our booth to experience the all-new ZEISS KINEVO 900, ZEISS CONVIVO and our brand new Advanced Visualization System. We are thrilled to share this year's ZEISS Scientific Events - that are specially set up to keep you at the center stage. "
Of course you won't see this on the OIL website.
There will be presentations from four experts in their fields, including Dr. Robert F. Spetzler from Barrow Nerological Institute on "10 year experience with Clinical and Research Confocal Endomicroscopy".
This was published in May, 2016:
https://www.sciencedaily.com/releases/2016/05/160504121816.htm
and includes this section -
"The research was conducted in the neurosurgery department of the Barrow Neurological Institute. Preul and the team came to their results by using the confocal laser endomicroscope on 74 brain tumor patients. The research was funded by the Barrow Neurological Foundation.
The eventual goal of this research is to develop the instrument to a degree that it is FDA approved and can speed up the process of pathology interpretation of brain tumor tissue. Hopefully this technology will improve brain tumor surgery by allowing for a more tailored removal of the tissue and allowing for more aggressive management at the tumor border.
Next steps for this research will see new refinements in the endomicroscope instrument and development of new tumor cell stains and probes that light up the tumor cells to an even greater degree."
The last scientific paper quoted on the OIL website is from 2010!
If we are not fully informed then I wonder if the BOD is aware of these results?
